Data / Research funding / Massachusetts / Joslin Diabetes Center
Joslin Diabetes Center: 63 NIH awards ($106.5M), fiscal years 2021 to 2026
Joslin Diabetes Center in Boston, MA is funded under 63 NIH awards ($106.5M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- UUUMQVGJNNX1
- State
- Massachusetts
Awards
63 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $8,420,615 | February 15, 1997 | March 31, 2027 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Epitranscriptomics in human obesity and type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $4,016,560 | July 1, 2024 | June 30, 2029 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Training Grant in Diabetes and Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,771,631 | July 1, 1977 | June 30, 2027 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,664,508 | September 20, 2022 | June 30, 2027 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Exercise Regulation of Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,417,714 | September 16, 2013 | January 31, 2028 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Developmental genes, miRNAs and adipose tissue | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,326,265 | December 14, 2009 | March 31, 2027 | KAHN, C RONALD | reporter.nih.gov |
| Novel Mechanisms of Exercise Training Effects on Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,320,917 | April 10, 2014 | December 31, 2028 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,160,264 | December 24, 2021 | November 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,003,444 | August 25, 2021 | July 31, 2025 | LAFFEL, LORI M | reporter.nih.gov |
| Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,970,989 | September 1, 2021 | May 31, 2026 | PATTI, MARY E | reporter.nih.gov |
| Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,895,718 | September 17, 2021 | June 30, 2027 | KAHN, C RONALD | reporter.nih.gov |
| Dissecting the thermogenic adipose niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,835,733 | September 1, 2022 | August 31, 2026 | TSENG, YU-HUA | reporter.nih.gov |
| Signaling mechanisms that detect stress and maintain homeostasis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,751,617 | July 20, 2017 | August 31, 2027 | KAHN, C RONALD | reporter.nih.gov |
| Causal connections between axon guidance proteins and early progressive kidney function decline in diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,713,884 | April 1, 2022 | January 31, 2027 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,712,858 | September 20, 2021 | July 31, 2025 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| Insulin Receptor Structure and Turnover | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,668,398 | April 15, 1982 | February 28, 2026 | KAHN, C RONALD | reporter.nih.gov |
| Gut microbial fermentation products of muscle-derived lactate as mediators of exercise and metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,469,326 | April 1, 2022 | March 31, 2027 | KOSTIC, ALEKSANDAR DAVID | reporter.nih.gov |
| Transcriptional and epigenetic regulation of thermogenic adipocyte program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,447,256 | April 6, 2022 | March 31, 2027 | TSENG, YU-HUA | reporter.nih.gov |
| Fibroblast Growth Factor and Energy Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,257,939 | July 3, 2015 | March 31, 2026 | TSENG, YU-HUA | reporter.nih.gov |
| Understanding, Predicting and Preventing Type 2 Diabetes in Youth, Boston Clinical Center (UPP Study) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,197,974 | March 10, 2023 | January 31, 2029 | ISGANAITIS, ELVIRA MARIE | reporter.nih.gov |
| Interaction between genes, environment, the microbiome and metabolome in type 2 diabetes and metabolic syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,171,533 | May 1, 2020 | January 31, 2026 | KAHN, C RONALD | reporter.nih.gov |
| Glucagon Pump Therapy for Post-Bariatric Hypoglycemia: Merging Physiology and Engineering | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,151,655 | September 20, 2023 | June 30, 2028 | PATTI, MARY E | reporter.nih.gov |
| Characterization of risk factors for excessive cardiovascular diseases (CVD) from circulating and cardiovascular tissues of people with well-controlled chronic type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,029,432 | September 18, 2024 | June 30, 2027 | KING, GEORGE L | reporter.nih.gov |
| Homeostasis functions of SKN-1A/Nrf1 | NIH | National Institute on Aging | 2021 to 2025 | $1,985,451 | March 1, 2017 | May 31, 2028 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration | NIH | National Eye Institute | 2021 to 2024 | $1,891,430 | March 1, 2016 | September 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Ribosome Heterogeneity as a Mechanism for Metabolic Regulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,764,859 | September 1, 2018 | August 31, 2024 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Lipotoxicity and Maintenance of Metabolic Health | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,762,959 | July 1, 2023 | April 30, 2027 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Understanding the role of the Complement Proteome in progressive Diabetic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,754,812 | April 30, 2020 | February 28, 2026 | NIEWCZAS, MONIKA ANNA | reporter.nih.gov |
| Functional Validation of Gene Modifications that Protect Beta Cells against Autoimmunity Identified by Genome-Wide CRISPR Cas9 Screening | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,673,100 | September 30, 2018 | February 28, 2025 | YI, PENG | reporter.nih.gov |
| Elucidating and targeting beta-cell senescence and its SASP | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,649,136 | May 10, 2022 | April 30, 2027 | AGUAYO-MAZZUCATO, CRISTINA | reporter.nih.gov |
| Role of IGF-1 and insulin receptors beta-cell survival | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,640,773 | March 1, 2004 | November 30, 2029 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Role of brown fat-derived specialized pro-resolving lipid mediators in inflammation and metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,620,754 | April 1, 2020 | January 31, 2025 | TSENG, YU-HUA | reporter.nih.gov |
| Mechanisms for Impaired Adaptation to Aerobic Exercise with Metabolic Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,607,583 | September 15, 2020 | July 14, 2024 | LESSARD, SARAH | reporter.nih.gov |
| Translational Programming of Beta-cells in Response to Glucose Toxicity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,431,505 | August 2, 2024 | May 31, 2027 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Animal Studies Investigating Molecular Transducers of Physical Activity | NIH | National Institute on Aging | 2021 to 2023 | $1,366,758 | December 15, 2016 | November 30, 2023 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,074,756 | July 1, 2024 | June 30, 2029 | SERWOLD, THOMAS F | reporter.nih.gov |
| A pilot study of fenofibrate to prevent kidney function loss in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,047,147 | August 19, 2021 | June 30, 2025 | DORIA, ALESSANDRO | reporter.nih.gov |
| Identifying Targets for Preventing Neurocognitive Complications in Youth with T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $952,320 | August 22, 2024 | June 30, 2029 | LAFFEL, LORI M | reporter.nih.gov |
| Joslin-BIDMC Postbac Program in Diabetes and Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $782,528 | September 1, 2024 | July 31, 2028 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $748,405 | September 3, 2020 | June 30, 2024 | LIPES, MYRA A | reporter.nih.gov |
| 9/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $711,381 | September 25, 2017 | May 31, 2028 | ROSAS, SYLVIA E | reporter.nih.gov |
| Maternal exercise during lactation to ignite infant metabolism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $657,909 | April 22, 2025 | March 31, 2030 | ISGANAITIS, ELVIRA MARIE | reporter.nih.gov |
| Evaluating clinical and pathological markers of cognitive decline and Alzheimer's dementia in long-duration type 1 diabetes. | NIH | National Institute on Aging | 2025 | $645,002 | September 1, 2025 | May 31, 2030 | SHAH, HETAL S. | reporter.nih.gov |
| Precision Monitoring: Understanding Momentary Affect, Glucose, and Self-care Behaviors in Adolescents and Young Adults with type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $572,371 | September 1, 2023 | July 31, 2028 | SHAPIRA, AMIT | reporter.nih.gov |
| A pilot clinical trial to assess feasibility, facilitators and barriers of continuous glucose monitoring in Asian Americans with type 2 diabetes | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2023 | $468,688 | September 23, 2022 | November 30, 2024 | KING, GEORGE L | reporter.nih.gov |
| Identifying metabolic mechanisms that regulate appetite and foodintake | NIH | National Institute on Aging | 2021 to 2022 | $467,951 | September 1, 2021 | May 31, 2023 | BLACKWELL, T KEITH | reporter.nih.gov |
| Mechanisms of exercise effects in obese humans: sex-specific regulation of novel adipose tissue function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $463,919 | April 1, 2018 | January 31, 2024 | MIDDELBEEK, ROELAND J | reporter.nih.gov |
| Post-lysosomal cholesterol trafficking networks | NIH | National Heart, Lung, and Blood Institute | 2021 | $427,832 | April 1, 2002 | December 31, 2022 | SCHAFFER, JEAN E. | reporter.nih.gov |
| In vivo gene editing of hematopoietic stem and progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 | $417,500 | March 1, 2018 | February 29, 2024 | WAGERS, AMY JO | reporter.nih.gov |
| Feeding Drives HSF1 Transcriptional Programs Required for Global Protein Synthesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $380,250 | May 2, 2018 | March 31, 2024 | SHOELSON, STEVEN E | reporter.nih.gov |
| Development of an intervention to target diabetes device use through an identity framework: ACCPTech (Adapt and Commit to CGM and Pump Technology) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $379,068 | April 1, 2024 | January 31, 2029 | COMMISSARIAT, PERSIS | reporter.nih.gov |
| Cellular Mechanisms that Promote or Prevent Lipotoxicity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $372,954 | September 1, 2003 | March 31, 2023 | SCHAFFER, JEAN E. | reporter.nih.gov |
| Identification of Pathways Required for High Glucose-Induced Oxidative Stress Associated With Diabetic Embryopathy by CRISPR-Generated Mutation Screen | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $211,250 | June 1, 2020 | May 31, 2023 | LOEKEN, MARY R | reporter.nih.gov |
| Pancreatic beta-cell glucose toxicity and mRNA translation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $181,500 | August 1, 2024 | December 31, 2025 | CHERUIYOT HARVEY, ABIGAEL | reporter.nih.gov |
| Interrogating the role of m6A mRNA methylation in the aging of the β-cell and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $180,000 | May 1, 2023 | April 30, 2025 | F DE JESUS, DARIO | reporter.nih.gov |
| Drivers of Human Insulin Resistance and Sex-specific Alterations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $150,583 | September 15, 2025 | July 31, 2028 | HAIDER, NIDA | reporter.nih.gov |
| Multi-omics approach to understanding the beneficial effects of exercise in diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $146,961 | July 1, 2020 | March 31, 2024 | VAMVINI, MARIA | reporter.nih.gov |
| Genotype-dependent cardiovascular and anti-inflammatory effects of fenofibrate | NIH | National Heart, Lung, and Blood Institute | 2021 | $134,992 | August 1, 2020 | July 31, 2023 | DORIA, ALESSANDRO | reporter.nih.gov |
| Replication Analysis to Identify Acute Molecular Responses to Exercise that Lead to Chronic Training Adaptations | NIH | National Institute on Aging | 2025 | $85,500 | September 23, 2025 | August 31, 2026 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Insulin regulates aging-associated genes through chromatin topology | NIH | National Institute on Aging | 2024 to 2025 | $74,080 | September 1, 2024 | August 31, 2026 | LIU, XIANGYU | reporter.nih.gov |
| The role of vascular endothelium in BAT expansion and remodeling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $40,028 | August 1, 2020 | July 31, 2021 | SHAMSI, FARNAZ | reporter.nih.gov |
| 7/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1 | August 20, 1994 | January 31, 2023 | MUNSHI, MEDHA N | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 35 | $22,244,215 | 0 | $0 |
| 2024 | 40 | $24,785,753 | 0 | $0 |
| 2023 | 36 | $21,222,388 | 0 | $0 |
| 2022 | 34 | $21,013,169 | 0 | $0 |
| 2021 | 35 | $17,233,708 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Diabetes
- Prevention
- Genetics
- Clinical Research
- Nutrition
- Obesity
- Autoimmune Disease
- Behavioral and Social Science
- Pediatric
- Physical Activity
- Biotechnology
- Aging
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.